FDA Inspection
SGS North America Inc.SGS North America Inc. – FDA Inspection, Jun 9, 2026
Record Details
This FDA Inspection record concerns SGS North America Inc., with an inspection on June 9, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 19f7bf6c-95d5-4ab7-b207-dd53edeedef6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1321138
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SGS North America Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2014 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 21, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SGS North America Inc.
- FDA Inspection 1211177 - 2023-08-01
- FDA Inspection 1027721 - 2017-08-30
- FDA Inspection 973286 - 2016-06-07
- FDA Inspection 862181 - 2014-01-21
- FDA Inspection 753526 - 2011-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.